文献速递睡眠呼吸障碍

利用新技术进行患者参与以提高气道正压治疗依从性的回顾性分析

Patient Engagement Using New Technology to Improve Adherence to Positive Airway Pressure Therapy: A Retrospective Analysis.
PubMed 文献 · Chest · 2017-11-15

该回顾性分析比较了接受主动患者参与(APE)技术与常规护理监测(UCM)的睡眠呼吸暂停患者的气道正压治疗依从性。共分析128,037例患者,经倾向性匹配后,APE组达到依从标准的比例(87.3%)高于UCM组(70.4%),平均每晚使用时间分别为5.9小时和4.9小时。结论认为在常规护理中加入现代技术可提高治疗依从性。

要点

  • APE技术使87.3%患者达到依从标准,高于UCM的70.4%。
  • APE组平均每晚使用5.9小时,UCM组为4.9小时。
  • 依从性困难患者使用APE后绝对改善17.6%。

核心结论

  • 在常规护理中加入现代技术可达到稳健的治疗依从率。
  • 采用技术进步可能帮助临床医生更有效、高效地治疗睡眠呼吸暂停患者。

研究设计与样本

  • 回顾性分析,比较APE与UCM患者的气道正压治疗依从性。
  • 数据来自两个云数据库(AirView和myAir),共分析128,037例睡眠呼吸暂停患者。
  • 按1:2比例(APE:UCM)基于基线特征进行倾向性匹配。

主要发现

  • APE组达到依从标准的患者比例为87.3%,UCM组为70.4%(P < .0001)。
  • APE组平均治疗使用时间为每晚5.9小时,匹配UCM组为每晚4.9小时(P < .0001)。
  • 治疗依从性困难的患者使用APE后依从性绝对改善17.6%。

关键数值与推荐

  • 主要结局采用美国Medicare的依从性定义。
  • 纳入条件:患者APE工具激活日期在UCM数据库治疗开始日期7天内。

临床怎么用

  • 可考虑在睡眠呼吸暂停患者管理中引入APE技术以提高依从性。
  • 需注意在做出强烈临床推荐前可能需要严格的随机对照试验。

局限性

  • 为回顾性分析,非随机对照试验。
  • 原文指出在做出强烈临床推荐前可能需要严格的随机对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sleep apnea has major neurocognitive and cardiovascular and metabolic risks. Treatment of sleep apnea is suboptimal because of variable adherence to existing therapies. METHODS: This trial compared positive airway pressure adherence among patients who were provided active patient engagement (APE) technology vs those who received usual care monitoring (UCM). The primary outcome was expressed by using the US Medicare definition of adherence. Adherence data from two cloud-based databases (AirView and myAir) were analyzed for patients with sleep apnea. Data were included if a patient's activation date in the APE tool was within 7 days of the therapy start date in the UCM database during a defined time window. Data were propensity matched in a 1:2 ratio (APE:UCM) based on baseline patient characteristics. RESULTS: A total of 128,037 patients were analyzed. Baseline characteristics were typical of a sleep clinic cohort. APE was associated with more patients achieving adherence criteria (87.3%) compared with UCM patients (70.4%; P < .0001 for the difference). Average therapy usage was 5.9 h per night in the APE group vs 4.9 h per night in the matched UCM patients (P < .0001). Patients with sleep apnea "struggling" with therapy adherence had a 17.6% absolute improvement in adherence using APE compared with UCM. CONCLUSIONS: Robust therapy adherence rates can be achieved by adding modern technology to usual care. Adopting advances in technology in care management may allow clinicians to more effectively and efficiently treat patients who have sleep apnea. Rigorous randomized controlled trials may be required before making strong clinical recommendations.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Malhotra A, Crocker ME, Willes L, et al. Patient Engagement Using New Technology to Improve Adherence to Positive Airway Pressure Therapy: A Retrospective Analysis. Chest. 2017. PMID: 29154970. doi:10.1016/j.chest.2017.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。